KAREN NORTON: Open Payments
NPI 1609808914 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 11 payments from 8 companies in 2025. Trend: 2023 $212 · 2024 $287 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $33 |
| Astellas Pharma US Inc | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: MYFEMBREE, Veozah, ZURZUVAE, Qelbree, The Cologuard Plus Collection Kit, Phexxi, SLYND.
Industry payments across NJ — which companies pay providers there.
